Paternal-Side Family History of Breast Cancer May Be Missed: Could Contribute to Inaccurate Screening
July 25, 2006 - Taking a family history is one of the most accessible genomic screens for breast cancer. However, a history of cancer on the paternal side may not be as well reported. In a study published in the September issue of the American Journal of Preventive Medicine, researchers from the Virginia Commonwealth University Massey Cancer Center and the University of Washington, Seattle found that subjects reported fewer family members with breast cancer on their father’s side than their mother’s. The authors point out that on a population basis, women should have equal numbers of maternal and paternal extended relatives (not including mothers) with breast cancer. This under-reporting could have serious consequences for the accuracy of screening for breast cancer.
Using survey data from April 2003 to March 2005 for Women’s Health Clinic patients without breast cancer, researchers found that while 16% of the participants reported a maternal relative with breast cancer, only 10% reported a paternal relative. Because mothers are much more likely to develop breast cancer than fathers, participants who reported a mother with breast cancer were excluded from the study.
There may be multiple explanations for this unexpected discrepancy. For this particular study, the family histories might be accurate. This would lead to a conflict with current thinking about the inheritance of breast cancer risk. Alternatively, excessive reporting of maternal cancers could have affected the data, but earlier studies of family history indicate that breast cancer reporting tends to be accurate. Finally, men may not be aware of familial breast cancer risk and may not communicate this information to their relatives. This factor could be important where fathers are not present in the home or are unknown to the child. This would contribute to inaccuracy of family history, although misinformation (as opposed to lack of information) about paternity should not affect the maternal– paternal ratio.
Writing in the article, John M. Quillin, PhD, suggests, “The most likely explanation for these findings may be under-reporting of breast cancer on the paternal side. Future studies are needed to look for modifiable explanations (e.g., genetics education, family communication specifically for maternal and paternal relatives, or medical documentation) of the discrepancy in the reporting of family history of breast cancer to improve the sensitivity of the family history screen.”
Dr. Quillin continues, “Disease prevention scientists need to be mindful of this discrepancy when using reported family history to design and implement breast cancer health interventions. Primary care physicians might pay particular attention to getting information about the father’s side of the family since patients may not know that paternal family history is also relevant for their health.”
The article is “Paternal Relatives and Family History of Breast Cancer” by John M. Quillin, PhD, Viswanathan Ramakrishnan, PhD, Joseph Borzelleca, MD, Joann Bodurtha, MD, Deborah Bowen, PhD, and Diane Baer Wilson, EdD.
The article appears in the American Journal of Preventive Medicine, Volume 31, Issue 3 (September 2006) published by Elsevier.
Full text of the article is available upon request. Contact email@example.com to obtain copies or to request interviews.
© 2006 American Journal of Preventive Medicine. All rights reserved. Unauthorized use prohibited.
About American Journal of Preventive Medicine
The American Journal of Preventive Medicine ( www.ajpm-online.net) is the official journal of The American College of Preventive Medicine (www.acpm.org) and the Association of Prevention Teaching and Research (www.atpm.org). It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.
The American Journal of Preventive Medicine is ranked 14th out of 99 Public, Environmental & Occupational Health titles and 16th out of 105 General and Internal Medicine titles according to the Thomson Scientific Institute for Scientific Information's 2005 Journal Citation Reports.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Charlotte Seidman, Managing Editor
Phone: 858 457 7292